Evidence map›Paper›PMID 24761165›Full record

ArticleMedical acupuncture2012

The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial.

Weidong Lu, Ursula A Matulonis, Julie E Dunn, Hang Lee, Anne Doherty-Gilman, Elizabeth Dean-Clower, Annekathryn Goodman, Roger B Davis, Julie Buring, Peter Wayne and 2 more

Open access · greenAbstract read
In one paragraph

Article in Medical acupuncture, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 5 pooled it
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 5 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Acupuncture for cancer pain in adults.The Cochrane database of systematic reviews · 2015
    Pooled it
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Acupuncture for Cancer-Induced Bone Pain in Animal Models: A Systemic Review and Meta-Analysis.Evidence-based complementary and alternative medicine : eCAM · 2020
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Weidong LuLeonard P. Zakim Center for Integrative Therapies, Dana-Farber Cancer Institute , Boston, MA. ; The New England School of Acupuncture , Newton, MA.
Ursula A MatulonisDepartment of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA.
Julie E DunnThe New England School of Acupuncture , Newton, MA.
Hang LeeBiostatistics Center, Massachusetts General Hospital , Boston, MA.
Anne Doherty-GilmanLeonard P. Zakim Center for Integrative Therapies, Dana-Farber Cancer Institute , Boston, MA.
Elizabeth Dean-ClowerLeonard P. Zakim Center for Integrative Therapies, Dana-Farber Cancer Institute , Boston, MA.
Annekathryn GoodmanDepartment of Gynecologic Oncology & Medicine, Massachusetts General Hospital , Boston, MA.
Roger B DavisOsher Center for Integrative Medicine, Harvard Medical School and Brigham and Women's Hospital , Boston, MA.
Julie BuringOsher Center for Integrative Medicine, Harvard Medical School and Brigham and Women's Hospital , Boston, MA.
Peter WayneOsher Center for Integrative Medicine, Harvard Medical School and Brigham and Women's Hospital , Boston, MA.
David S RosenthalLeonard P. Zakim Center for Integrative Therapies, Dana-Farber Cancer Institute , Boston, MA.
Richard T PensonDepartment of Gynecologic Oncology & Medicine, Massachusetts General Hospital , Boston, MA.
Dana-Farber Cancer Institute · USMassachusetts General Hospital · US

Funding

NESA Acupuncture Research CollaborativeU19AT002022 · NCCIH · NEW ENGLAND SCHOOL OF ACUPUNCTURE · PI WAYNE, PETER MICHAEL · 2003 to 2009
$4.0M
NCCIH NIH HHS U19 AT002022
6 · The paper itself

Abstract

backgroundWithin a pilot trial regarding chemotherapy-induced neutropenia, the secondary aim of the main study was explored. This involved measuring the effects-as shown on two key measurement scales reflecting quality of life (QoL)-of verum versus sham acupuncture on patients with ovarian cancer during chemotherapy.

objectiveThe aim of this substudy was to determine the feasibility of determining the effects of verum acupuncture versus sham acupuncture on QoL in patients with ovarian cancer during chemotherapy.

designThis was a randomized, sham-controlled trial.

settingThe trial was conducted at two cancer centers. PATIENTS: Patients with ovarian cancer (

interventionThe participants were given either active or sham acupuncture 1 week prior to cycle 2 of chemotherapy. There were ten sessions of acupuncture, with manual and electro-stimulation over a 4-week period.

main outcome measuresThe European Organization for Research and Treatment of Cancer-Quality-of-Life Questionnaire-Core 30 Item (EORTC-QLQ-C30) and the Quality of Life Questionnaire-Ovarian Cancer Module-28 Item (QLQ-OV28) were administered to the patients at baseline and at the end of their acupuncture sessions.

resultsOf the original 21, 15 patients (71%) completed the study, and 93% of them completed the questionnaires. The EORTC-QLQ-C30 subscores were improved in the acupuncture arm, including the mean scores of social function (SF), pain, and insomnia (

conclusionsIt appears feasible to conduct a randomized sham-controlled acupuncture trial measuring QoL for patients with ovarian cancer who are undergoing chemotherapy. Acupuncture may have a role in improving QoL during chemotherapy.

Indexed as

AcupunctureChemotherapyEORTCNeutropeniaOvarian CancerQuality of LifeRandomized Controlled Trial

Identifiers

PMID24761165
PMCPMC3579196
OpenAlexW2011038523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.